Humacyte (HUMA) Total Debt (2020 - 2026)
Humacyte (HUMA) posted quarterly Total Debt of $35.9 million for Q1 2026, down 47.29% year-over-year from $68.1 million in Q1 2025, and up 1.2% quarter-over-quarter from $35.4 million in Q4 2025.
Humacyte (HUMA) Total Debt (2020 - 2026) Analysis & Trends
Humacyte (HUMA) has reported Total Debt for 7 consecutive years, with $35.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Debt fell 47.29% year-over-year to $35.9 million; the TTM figure through Mar 2026 stood at $35.9 million (down 47.29% YoY), while the FY2025 annual figure was $35.4 million, up 3904.97% from the prior year.
- Total Debt advanced to $35.9 million in Q1 2026 per HUMA's latest filing, from $35.4 million in the prior quarter.
- Across five years, Total Debt topped out at $70.7 million in Q2 2025 and bottomed at $885000.0 in Q4 2024.
- Historically, Total Debt has averaged $38.4 million across 5 years, with a median of $35.9 million in 2026.
- Annual changes were most pronounced in 2022 — Total Debt soared 277290.0% — and 2024, when it slumped 97.71%.
- Humacyte's Total Debt stood at $28.9 million in 2022, then jumped by 33.53% to $38.6 million in 2023, then plunged by 97.71% to $885000.0 in 2024, then soared by 3904.97% to $35.4 million in 2025, then advanced by 1.2% to $35.9 million in 2026.
- Business Quant data shows HUMA's Total Debt at $35.9 million in Q1 2026, $35.4 million in Q4 2025, and $20.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.34 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 770.36 Mn |
| 10 | Humacyte | 158.12 Mn | 158.12 Mn | -825,000.00 | 36.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 36.32 Mn |
| Mar 31, 2026 | 35.87 Mn |
| Dec 31, 2025 | 35.44 Mn |
| Sep 30, 2025 | 20.75 Mn |
| Jun 30, 2025 | 70.66 Mn |
| Mar 31, 2025 | 68.05 Mn |
| Dec 31, 2024 | 885,000.00 |
| Sep 30, 2024 | 62.12 Mn |
| Jun 30, 2024 | 60.08 Mn |
| Mar 31, 2024 | 57.96 Mn |
| Dec 31, 2023 | 38.60 Mn |
| Sep 30, 2023 | 37.29 Mn |
| Jun 30, 2023 | 36.25 Mn |
| Mar 31, 2023 | 12.86 Mn |
| Dec 31, 2022 | 28.91 Mn |
| Sep 30, 2022 | 28.57 Mn |
| Jun 30, 2022 | 30.00 Mn |
| Mar 31, 2022 | 27.74 Mn |
| Dec 31, 2021 | 27.36 Mn |
| Sep 30, 2021 | 17.93 Mn |